ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2024, Vol. 33 ›› Issue (2): 121-126.DOI: 10.3969/j.issn.1006-298X.2024.02.004

• 论著 • 上一篇    下一篇

维持性血液透析患者血清β-catenin水平与腹主动脉钙化的关系

  

  • 出版日期:2024-04-28 发布日期:2024-04-23

Serum β-catenin and abdominal aortic calcification in maintenance hemodialysis patients

  • Online:2024-04-28 Published:2024-04-23

摘要: 目的:探讨维持性血液透析(MHD)患者血清β-catenin水平与腹主动脉钙化(AAC)的关系。
方法:选取上海交通大学医学院附属仁济医院宝山分院MHD患者70例,使用腹部侧位平片检测AAC情况,根据CORD研究分组方法,将患者分为无或轻度钙化组、中度钙化组和重度钙化组。采用 ELISA法检测患者血清β-catenin水平,观察MHD患者血清β-catenin水平与AAC评分(AACS)及人口学特性和生化指标的关系。
结果:本组MHD患者AAC发生率为70%。腹主动脉重度钙化组血清β-catenin水平显著高于中度钙化组、无或轻度钙化组(P<0.05);中度钙化组血清β-catenin水平亦高于无或轻度钙化组(P<0.05)。相关性分析结果显示,MHD患者血清β-catenin水平与AACS、透析龄、甲状旁腺激素、血磷成正相关。Logistic 回归分析结果显示,β-catenin水平升高、高体质量指数及高C反应蛋白水平是MHD患者发生AAC的独立危险因素(P<0.05),而血清白蛋白水平升高则属于保护因素(P<0.05)。血清β-catenin预测AAC的曲线下面积(AUC)为0.864(95%CI 0.766~0.961,P=0.000),约登指数为0.693,对应血清β-catenin水平值为211.63 pg/ml,其预测AAC的灵敏度为91.70%,特异度为77.60%。
结论:MHD患者血清β-catenin升高可能与AAC相关。


关键词: 维持性血液透析, β-catenin, 腹主动脉钙化

Abstract: Objective:To investigate the relationship between serum β-catenin level and abdominal aortic calcification (AAC) in maintenance hemodialysis (MHD) patients.
Methodology:A total of 70 MHD patients in our hospital were selected and AAC was detected using lateral abdominal plain film. According to the CORD grouping method, the patients were divided into three groups: no or mild calcification group, moderate calcification group and severe calcification group. Serum β-catenin level was detected by ELISA, and the relationship between serum β-catenin level and AAC score (AACS), demographic characteristics and biochemical indexes of MHD patients was observed.
Results:The incidence of AAC in MHD patients was 70%. The serum β-catenin level of severe abdominal aortic calcification group was significantly higher than that of moderate, no or mild calcification group, and the difference was statistically significant (P<0.05). The serum β-catenin level in moderate calcification group was also higher than that in no or mild calcification group (P<0.05). Correlation analysis showed that serum β-catenin level was positively correlated with AACS, dialysis age, parathyroid hormone and blood phosphorus in MHD patients. Logistic regression analysis showed that the increase of β-catenin level, high body mass index and high CRP level were independent risk factors for AAC in MHD patients (P<0.05), while the increase of serum albumin level was a protective factor (P<0.05). The area under the curve (AUC) of serum β-catenin predicted AAC was 0.864 (95%CI 0.766~0.961, P=0.000), the Yoden index was 0.693, corresponding to the serum β-catenin level was 211.63pg/ml, the sensitivity of AAC prediction was 91.70%, the specificity was 77.60%.
Conclusion:The increase of serum β-catenin in MHD patients may be related to AAC.


Key words: maintenance hemodialysis, β-catenin, abdominal aorta calcified